NOX4 and non-small cell lung carcinoma: Previous studies have shown that NOX4 has the potential to promote the progression of non-small cell lung cancer (NSCLC), colorectal cancer, and pancreatic cancer while CYBB has been approved to enhance the metastasis of melanoma in mice [23,24,25,26].